Requires health insurance coverage and limits cost sharing for certain birth control methods.
Impact
If passed, this bill would significantly affect state laws regarding health insurance mandates, specifically those surrounding reproductive health. By ensuring that insurance plans include coverage for birth control without cost-sharing such as copayments or deductibles, the bill aims to ease economic burdens on families and individuals, particularly women. The implications of this change might lead to increased utilization of contraceptive methods, thereby potentially reducing unintended pregnancies and enhancing overall public health outcomes.
Summary
Senate Bill No. 1492, sponsored by Senator Shirley K. Turner, is focused on mandating health insurance coverage for certain birth control methods while simultaneously limiting the cost-sharing required from patients. The bill seeks to amend previous legislation to ensure that outpatient prescription drugs, specifically female contraceptives and male sterilization procedures, are covered under health insurance policies in New Jersey. The proposed legislation aims to enhance accessibility to contraceptive methods, promoting reproductive health and planning for individuals who may face financial barriers to obtaining these essential healthcare services.
Contention
However, the bill may face contention, particularly from religious organizations and employers who could assert their right to exemption based on religious beliefs. The legislation allows certain religious employers to exclude coverage that conflicts with their bona fide religious convictions, which could lead to debates about reproductive rights versus religious freedoms. Critics might argue that allowing such exemptions undermines the intent of the bill, as it could result in certain groups not receiving equitable access to contraceptive services.
Requires Medicaid provide health benefits coverage, and places certain requirements on insurers and State Health Benefits Program regarding existing mandate on health benefits coverage, for certain over-the-counter contraceptives.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.